|
Glenmark Pharmaceuticals Ltd.
|
Balance Sheet
|
|
|
You can view the
Balance Sheet
for the last 5 years.
|
Market Cap. (Rs.)
|
70979.51 Cr.
|
P/BV
|
6.46
|
Book Value (Rs.)
|
389.58
|
|
52 Week High/Low (Rs.)
|
2538/1793
|
FV/ML
|
1/1
|
P/E(X)
|
52.12
|
|
Bookclosure
|
31/08/2026
|
EPS (Rs.)
|
48.25
|
Div Yield (%)
|
0.20
|
|
(Rs. in Crs.)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| No. of Equity Shares (in Lacs) | 2821.88 | 2821.88 | 2821.88 | 2821.68 | 2821.68 |
| | | | | | |
| EQUITIES AND LIABILITIES | | | | | |
| SHAREHOLDER'S FUNDS | | | | | |
| Equity Share Capital | 28.22 | 28.22 | 28.22 | 28.22 | 28.22 |
| Total Share Capital | 28.22 | 28.22 | 28.22 | 28.22 | 28.22 |
| | | | | | |
| Reserves and Surplus | 10483.89 | 8821.22 | 7801.48 | 9445.71 | 9058.43 |
| Total Reserves and Surplus | 10483.89 | 8821.22 | 7801.48 | 9445.71 | 9058.43 |
| Employees Stock Options | 0.00 | 0.00 | 18.23 | 0.00 | 0.00 |
| Total Shareholders Funds | 10512.11 | 8849.44 | 7847.93 | 9473.92 | 9086.65 |
| Minority Interest | -0.32 | -0.37 | -0.38 | 365.34 | 351.47 |
| | | | | | |
| NON-CURRENT LIABILITIES | | | | | |
| Long Term Borrowings | 0.00 | 512.70 | 0.00 | 3852.14 | 2571.74 |
| Deferred Tax Liabilities [Net] | 1.23 | 58.59 | 0.28 | 42.95 | 31.50 |
| Other Long Term Liabilities | 2841.81 | 662.17 | 692.21 | 591.80 | 352.50 |
| Long Term Provisions | 176.61 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Non-Current Liabilities | 3019.66 | 1233.46 | 692.49 | 4486.89 | 2955.74 |
| | | | | | |
| CURRENT LIABILITIES | | | | | |
| Short Term Borrowings | 0.00 | 1681.50 | 990.60 | 495.58 | 1098.61 |
| Trade Payables | 3743.87 | 2579.53 | 2535.93 | 2391.86 | 2288.66 |
| Other Current Liabilities | 1562.47 | 1109.92 | 1650.94 | 1650.54 | 810.78 |
| Short Term Provisions | 1070.09 | 596.08 | 641.12 | 507.55 | 491.38 |
| Total Current Liabilities | 6376.43 | 5967.02 | 5818.59 | 5045.53 | 4689.43 |
| | | | | | |
| Total Capital And Liabilities | 19907.88 | 16049.55 | 14358.62 | 19371.68 | 17083.29 |
| | | | | | |
| ASSETS | | | | | |
| NON-CURRENT ASSETS | | | | | |
| Tangible Assets | 3889.57 | 3319.37 | 3118.15 | 3904.16 | 3690.63 |
| Intangible Assets | 1942.11 | 1097.19 | 1024.65 | 2224.61 | 2136.60 |
| Capital Work-In-Progress | 427.87 | 541.99 | 419.32 | 1115.18 | 921.09 |
| Intangible Assets Under Development | 481.26 | 292.84 | 242.56 | 136.08 | 88.78 |
| Fixed Assets | 6740.81 | 5251.39 | 4804.68 | 7380.02 | 6837.10 |
| Goodwill On Consolidation | 82.86 | 70.27 | 67.36 | 73.62 | 60.02 |
| Non-Current Investments | 42.36 | 56.36 | 789.66 | 44.65 | 49.62 |
| Deferred Tax Assets [Net] | 1246.61 | 1124.11 | 1049.72 | 1805.91 | 1686.12 |
| Other Non-Current Assets | 495.53 | 251.97 | 219.11 | 193.75 | 168.08 |
| Total Non-Current Assets | 8608.17 | 6754.09 | 6930.54 | 9497.96 | 8800.94 |
| | | | | | |
| | | | | | |
| CURRENT ASSETS | | | | | |
| Inventories | 3430.78 | 3028.53 | 2513.05 | 2977.79 | 2499.83 |
| Trade Receivables | 4963.35 | 3341.95 | 1858.41 | 4098.61 | 3101.14 |
| Cash And Cash Equivalents | 1176.26 | 1705.23 | 1659.46 | 1469.70 | 1411.52 |
| OtherCurrentAssets | 1729.32 | 1219.76 | 1397.16 | 1327.63 | 1269.87 |
| Total Current Assets | 11299.71 | 9295.47 | 7428.08 | 9873.72 | 8282.35 |
| | | | | | |
| Total Assets | 19907.88 | 16049.55 | 14358.62 | 19371.68 | 17083.29 |
| | | | | | |
| OTHER INFORMATION | | | | | |
| | | | | | |
| CONTINGENT LIABILITIES, COMMITMENTS | | | | | |
| Contingent Liabilities | 950.73 | 936.54 | 1193.96 | 477.58 | 559.75 |
| | | | | | |
| BONUS DETAILS | | | | | |
| Bonus Equity Share Capital | 15.84 | 15.84 | 15.84 | 15.84 | 15.84 |
| | | | | | |
| NON-CURRENT INVESTMENTS | | | | | |
| Non-Current Investments Quoted Market Value | 0.00 | 0.00 | 0.00 | 0.07 | 0.05 |
| Non-Current Investments Unquoted Book Value | 0.00 | 0.00 | 0.00 | 44.58 | 49.58 |